Company Short-Term Debts: Harvard Bioscience, Inc. (HBIO)

harvardbioscience.com (HBIO) - corporate logo

Harvard Bioscience (HBIO) short-term liabilities reflect the impact of management's strategy to refresh the product line in favor of profitable automation systems. This trend is driven by scaling the offering of organoid analysis tools to increase B2B revenues. The 0.00 level captures the current state of obligations, which are being adjusted through factory optimization and high demand for electroporation equipment.

HBIO (Harvard Bioscience) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for Harvard Bioscience Inc. (HBIO)

- price and consensus price forecast:
Stock Price Harvard Bioscience, Inc.|HBIO - Analyst Median Target
- market capitalization data:
Market Capitalization Harvard Bioscience, Inc.|HBIO - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Harvard Bioscience|HBIO - Book Capitalization|Market Value to Book Value Ratio harvardbioscience.com|HBIO - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Harvard Bioscience|HBIO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Harvard Bioscience|HBIO - Company Total Debt Obligations|Debt to Book Capitalization Ratio Harvard Bioscience, Inc.|HBIO - Company Long-Term Indebtedness|Company Short-Term Debt Harvard Bioscience
Fundamental company valuation:Harvard Bioscience
Signature product of Harvard Bioscience Inc.

This indicator reflects the total liabilities of Harvard Bioscience (HBIO) with a maturity horizon of up to twelve months, capturing the liquid burden on capital. By analyzing the volume of short-term liabilities, an investor assesses the company's ability to finance the delivery of high-precision bioanalysis systems without the risk of cash flow gaps, which determines the balance between financial stability and the pace of business scaling.

Competitor analysis for Harvard Bioscience

Company Short-Term Debts ISRG (Intuitive)|DHR - Short-Term Debt Volume|BDX (Becton, Dickinson and Company) - Company Short-Term Debts|STERIS Group (STE) - Company Current Liabilities|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts BAX|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt Stevanato Group SpA STVN|Company Current Liabilities Teleflex Inc|Company Short-Term Loans and Borrowings Merit Medical Corp MMSI|Company Short-Term Debts NVST (Envista Holdings)|ICUI: Short-Term Debt Volume|Company Short-Term Debt Dentsply Sirona|LMAT (LeMaitre Vascular Inc) - Company Short-Term Indebtedness|ATRC: Company Short-Term Debt|Short-Term Debt Volume STAAR Surgical Co (STAA)|Company Current Liabilities ChromaDex|Amount of Current Liabilities ZIMV (zimvie.com)|Company Short-Term Debt AngioDynamics|CERS - Company Short-Term Loans and Borrowings|Alpha Teknova Inc - Company Current Liabilities|MGRM: Company Short-Term Debts|STSS (sharpstechnology.com) - Company Short-Term Debt|InfuSystem Holdings, Inc. (INFU) - Company Current Liabilities|Company Short-Term Debts UTMD (Utah Medical Products, Inc.)|Short-Term Debt KRMD|Company Short-Term Debt Nyxoah, S.A. NYXH|Company Short-Term Indebtedness Microbot Medical, Inc MBOT|Company Current Liabilities Pro-Dex, Inc. (PDEX)|zentek.com - Amount of Current Liabilities|Company Short-Term Debt ELUT (Elutia)|MLSS - Short-Term Debt Volume|Company Short-Term Debts NEXGEL, Inc NXGL|Retractable Technologies, Inc. (RVP) - Company Short-Term Loans and Borrowings|FEMY (Femasys Inc.) - Company Short-Term Debts|Company Short-Term Debts MHUA|Predictive Oncology (POAI) - Company Short-Term Debt|Company Short-Term Loans and Borrowings callanjmb.com CJMB|Company Current Liabilities Atrion Corp ATRI|Company Short-Term Debt NeuroMetrix Corporation NURO